Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022

SELL
$1.19 - $2.06 $923,434 - $1.6 Million
-775,995 Reduced 28.64%
1,933,041 $2.38 Million
Q2 2022

Jul 26, 2022

SELL
$1.59 - $2.7 $2.17 Million - $3.69 Million
-1,365,903 Reduced 33.52%
2,709,036 $4.53 Million
Q1 2022

May 04, 2022

SELL
$2.02 - $3.92 $113,883 - $221,001
-56,378 Reduced 1.36%
4,074,939 $10 Million
Q1 2021

May 06, 2021

BUY
$4.59 - $18.74 $19 Million - $77.4 Million
4,131,317 New
4,131,317 $38.6 Million

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $510M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Yong Rong (Hk) Asset Management LTD Portfolio

Follow Yong Rong (Hk) Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yong Rong (Hk) Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Yong Rong (Hk) Asset Management LTD with notifications on news.